Paloma Partners’s PharMerica Corporation PMC Stock Holding History

Paloma Partners’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-63,199	Closed	-$1.85M	–	2517
2017 Q3	$1.85M	Buy	63,199 +43,599	+222%	+$1.22M	0.03%	796
2017 Q2	$515K	Buy	+19,600	New	+$482K	0.01%	1529
2017 Q1	–	Sell	-16,742	Closed	-$422K	–	2403
2016 Q4	$422K	Sell	16,742 -12,169	-42%	-$307K	﹤0.01%	1592
2016 Q3	$811K	Sell	28,911 -15,700	-35%	-$402K	0.01%	1159
2016 Q2	$1.1M	Buy	+44,611	New	+$1.11M	0.01%	1091
2016 Q1	–	Sell	-47,625	Closed	-$1.67M	–	2196
2015 Q4	$1.67M	Buy	+47,625	New	+$1.49M	0.04%	434
2015 Q3	–	Sell	-6,122	Closed	-$205K	–	2145
2015 Q2	$205K	Buy	+6,122	New	+$188K	﹤0.01%	1548

Paloma Partners's PMC Position: Q4 2017 in Review

Paloma Partners sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 63,199 shares — an estimated $1.85M sold.

Paloma Partners first reported a position in PMC in Q2 2015 and held it in 7 quarters. The position peaked at $1.85M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Paloma Partners reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Paloma Partners sold 63,199 PharMerica Corporation shares in Q4 2017, an estimated $1.85M.
Paloma Partners first reported a position in PharMerica Corporation in Q2 2015 and held it in 7 quarters.
Paloma Partners's PharMerica Corporation position peaked at $1.85M in Q3 2017.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Paloma Partners's 13F filing for Q4 2017, filed 14 Feb 2018.